About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Webinar on Patent Restoration | Main | Supernus Pharmaceuticals, Inc. v. Iancu (Fed. Cir. 2019) »

January 26, 2019

Webinar on Blocking Patents

Strafford #1Strafford will be offering a webinar entitled "Blocking Patents: Impact of Acorda Therapeutics on Obviousness Analysis -- Non-Obviousness and Commercial Success, Cross Licensing, Searches" on January 31, 2019 from 1:00 to 2:30 pm (EST).  Mark Kachner of Knobbe Martens, Sarah A. Kagan of Banner & Witcoff, and Patent Docs author Kevin E. Noonan of McDonnell Boehnen Hulbert & Berghoff will discuss the expanded doctrine of blocking patents, the Acorda decision and secondary considerations, and also address how the decision impacts the obviousness analyses, licensing, and invalidity/validity/opposition searches.  The webinar will review the following issues:

• How does the Acorda decision change the playing field for blocking patents?
• What impact does the expanded doctrine of blocking patents have on the obviousness analysis?
• What steps can patent counsel take to overcome the notion of the hypothetical researcher whose concern about infringing on a prior patent would deter him/her from commercial success?

The registration fee for the webcast is $297.  Those interested in registering for the webinar, can do so here.

Posted at 10:42 PM in Conferences & CLE's |

Comments

The comments to this entry are closed.

January 2025

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Categories

Archives

More...